2017 Annual Meeting | N4 - Neuroscience in the Clinic: Zika Virus: The Global Outbreak of a Neurotropic Virus
| 01:00 PM - 01:05 PM | Luncheon |
Introduction
Omar Siddiqi, MD |
| 01:00 PM - 01:15 PM | Speaker |
Zika Case Presentation-Adult Manifestation
Kiran Thakur, MD, FAAN |
| 01:00 PM - 03:00 PM | Abstract |
001 - Expanding Spectrum of Neurologic manifestations with Zika Virus Infection
Laura S. Surillo Dahdah, MD |
| 01:00 PM - 03:00 PM | Abstract |
002 - Neuroviruses Emerging in the Americas Study (NEAS): The Colombian experience during the 2016 outbreak of Zika virus infection
|
| 01:15 PM - 01:45 PM | Speaker |
Epidemiological Update
James J. Sejvar, MD, FAAN |
| 01:45 PM - 02:15 PM | Speaker |
Neurovirology and Neuropathogenesis
Carlos A. Pardo-Villamizar, MD |
| 02:15 PM - 02:20 PM | Speaker |
Introduction of Science Presentations
Allen J. Aksamit, Jr., MD, FAAN, Arun Venkatesan, MD, PhD |
| 02:20 PM - 02:30 PM | Speaker |
N4.001: Expanding Spectrum of Neurologic manifestations with Zika Virus Infection
Laura S. Surillo Dahdah, MD |
| 02:30 PM - 02:40 PM | Speaker |
N4.002: Neuroviruses Emerging in the Americas Study (NEAS): The Colombian experience during the 2016 outbreak of Zika virus infection
|
| 02:40 PM - 03:00 PM | Speaker |
Panel Discussion
|
| Allen J. Aksamit, Jr., MD, FAAN | Dr. Aksamit has nothing to disclose. |
| Kiran Thakur, MD, FAAN | Dr. Thakur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. |
| Arun Venkatesan, MD, PhD | Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from U.S. DOD. |
| Omar Siddiqi, MD | The institution of Dr. Siddiqi has received research support from NIH. |
| James J. Sejvar, MD, FAAN | Dr. Sejvar has nothing to disclose. |
| Carlos A. Pardo-Villamizar, MD | The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research . |
| Laura S. Surillo Dahdah, MD | No disclosure on file |
| No disclosure on file | |
| Marie B. Hidalgo, MD | No disclosure on file |
| Gustavo E. Ramos, MD | Dr. Ramos has nothing to disclose. |
| Sonia M. Caraballo-Cartagena, MD | Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. |
| Jose R. Carlo, MD, FAAN | Dr. Carlo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for sanofi. Dr. Carlo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various insurance companies . |
| ANGELA GOMEZ | No disclosure on file |
| Tania C. Zayas Torres, MD | No disclosure on file |
| Lyda Osorio | Lyda Osorio has nothing to disclose. |
| Beatriz Parra | Beatriz Parra has nothing to disclose. |
| Paula Barreras, MD | The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from 好色先生. |
| Marisel Vazquez, MD | Dr. Vazquez has nothing to disclose. |
| Gonzalo Zuniga | No disclosure on file |
| Jorge A. Angarita Diaz | No disclosure on file |
| Guillermo Gonzalez-Manrique | Guillermo Gonzalez-Manrique has nothing to disclose. |
| Gustavo Pradilla-Ardila, MD | No disclosure on file |
| Carlos A. Luciano, MD, FAAN | Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for SIMED. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Vazquez-Irizarry Law Office. The institution of Dr. Luciano has received research support from National Institutes of Health. Dr. Luciano has received personal compensation in the range of $100,000-$499,999 for serving as a Professor and Chair with University of Puerto Rico. |
| Maria I. Reyes-Mantilla, MD | Dr. Reyes-Mantilla has nothing to disclose. |
| Cindy Beltran | No disclosure on file |
| Anupama Kumar, PhD | No disclosure on file |
| Jose Avila-Ornelas, MD | Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Banner Pharmaceuticals. |
| David R. Cornblath, MD | Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cigna. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MPTP. Dr. Cornblath has received intellectual property interests from a discovery or technology relating to health care. |